Cargando…

Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation

Left ventricular (LV) hypertrophy at electrocardiography (ECG) predicts incident atrial fibrillation (AF). However, the diagnostic performance of ECG for diagnosis of LV hypertrophy in patients with AF is still not well characterized. We analyzed 563 hypertensive patients enrolled in the Umbria-Atri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angeli, Fabio, Verdecchia, Paolo, Cavallini, Claudio, Aita, Adolfo, Turturiello, Dario, Mazzotta, Giovanni, Trapasso, Monica, De Fano, Michelantonio, Reboldi, Gianpaolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803070/ https://www.ncbi.nlm.nih.gov/pubmed/33447738 http://dx.doi.org/10.1016/j.ijchy.2019.100004

Ejemplares similares

Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry
por: Angeli, Fabio, et al.
Publicado: (2019)

The revolution of the anti-diabetic drugs in cardiology
por: Verdecchia, Paolo, et al.
Publicado: (2020)

Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension
por: Verdecchia, Paolo, et al.
Publicado: (2017)

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial
por: Hijazi, Ziad, et al.
Publicado: (2019)

Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study
por: Verdecchia, Paolo, et al.
Publicado: (2018)

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later
por: Angeli, Fabio, et al.
Publicado: (2021)

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
por: Angeli, Fabio, et al.
Publicado: (2023)

Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis
por: Angeli, Fabio, et al.
Publicado: (2022)

COVID-19, vaccines and deficiency of ACE(2) and other angiotensinases. Closing the loop on the "Spike effect"
por: Angeli, Fabio, et al.
Publicado: (2022)

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction
por: Verdecchia, Paolo, et al.
Publicado: (2008)

Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
por: Vedovati, Maria Cristina, et al.
Publicado: (2019)

Association of Arterial Stiffness and Electrocardiography-Determined Left Ventricular Hypertrophy with Left Ventricular Diastolic Dysfunction
por: Hsu, Po-Chao, et al.
Publicado: (2012)

The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure()
por: Angeli, Fabio, et al.
Publicado: (2023)

Comparative assessment of angiotensin receptor blockers in different clinical settings
por: Verdecchia, Paolo, et al.
Publicado: (2009)

Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study
por: Zhang, Wei, et al.
Publicado: (2019)

Can left ventricular hypertrophy on electrocardiography detect severe aortic valve stenosis?
por: Mino, Takashi, et al.
Publicado: (2020)

Improved evaluation of left ventricular hypertrophy using the spatial QRS-T angle by electrocardiography
por: Maanja, Maren, et al.
Publicado: (2022)

Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
por: Angeli, Fabio, et al.
Publicado: (2021)

Is Electrocardiography‐Left Ventricular Hypertrophy an Obsolete Marker for Determining Heart Failure Risk With Hypertension?
por: Ferdinand, Keith C., et al.
Publicado: (2019)

CoAt-Mixer: Self-attention deep learning framework for left ventricular hypertrophy using electrocardiography
por: Ryu, Ji Seung, et al.
Publicado: (2023)

Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
por: Reboldi, Gianpaolo, et al.
Publicado: (2009)

Hypertension and myocarditis following COVID-19 vaccination. Two sides of the coin?()
por: Angeli, Fabio, et al.
Publicado: (2023)

How much does the presentation pattern of atrial fibrillation affect thrombo-embolic risk and mortality?
por: Turturiello, Dario, et al.
Publicado: (2023)

Nonlinear Analysis of Electrocardiography Signals for Atrial Fibrillation
por: Sezgin, Necmettin
Publicado: (2013)

Combined Use of Electrocardiography and Ultrasound to Detect Cardiac and Pulmonary Involvement after Recovery from COVID-19 Pneumonia: A Case Series
por: Marazzato, Jacopo, et al.
Publicado: (2021)

Diuretic Treatment of Hypertension
por: Grossman, Ehud, et al.
Publicado: (2011)

Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons
por: Verdecchia, Paolo, et al.
Publicado: (2014)

SARS-CoV-2 vaccines: Lights and shadows
por: Angeli, Fabio, et al.
Publicado: (2021)

Clinical Data, Chest Radiograph and Electrocardiography in the Screening for Left Ventricular Hypertrophy: The CAR(2)E(2) Score
por: Matusik, Patrycja S., et al.
Publicado: (2022)

The Association Between Left Ventricular Hypertrophy and the Occurrence and Prognosis of Atrial Fibrillation: A Meta-Analysis
por: Xiang, Huaqiang, et al.
Publicado: (2021)

Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study
por: Marazzato, Jacopo, et al.
Publicado: (2021)

Assessment of Left Ventricular Hypertrophy (LVH) Criteria by Surface Electrocardiography in a Sample of Iraqi Patients with Systemic Arterial Hypertension
por: Altaweel, Rafid Bashir, et al.
Publicado: (2020)

Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
por: Angeli, Fabio, et al.
Publicado: (2022)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
por: Cuspidi, Cesare, et al.
Publicado: (2008)

Increased red blood cell distribution width might predict left ventricular hypertrophy in patients with atrial fibrillation
por: Yao, Hui-Ming, et al.
Publicado: (2020)

Six-lead electrocardiography compared to single-lead electrocardiography and photoplethysmography of a wrist-worn device for atrial fibrillation detection controlled by premature atrial or ventricular contractions: six is smarter than one
por: Bacevicius, Justinas, et al.
Publicado: (2023)

Echocardiography in Low‐Risk Hypertensive Patients
por: Mancusi, Costantino, et al.
Publicado: (2019)

Addition of N-terminal Pro-B-type Natriuretic Peptide Levels to Electrocardiography Criteria for Detection of Left Ventricular Hypertrophy: The ARIRANG Study
por: Ahn, Min-Soo, et al.
Publicado: (2015)

Heart monitoring using left ventricle impedance and ventricular electrocardiography in left ventricular assist device patients
por: Her, Keun, et al.
Publicado: (2015)

Is the Diagnostic Value of Electrocardiography for the Measurement of Left Ventricular Mass Index Underestimated?
por: Khani, Afshin
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_am9o15i597fr0pbe9f1glfqk8l